PVP Ventures pivots to healthcare with key acquisitions

PVP Ventures Limited will hold its 34th Annual General Meeting on September 25, 2025, to approve its Annual Report for fiscal year 2024-25, which outlines a significant strategic shift. The company is diversifying into the healthcare sector, having initiated B2B models in cancer, renal care, senior care, and specialty diagnostics, primarily targeting Tier 2 and Tier 3 cities. This move follows a robust monetization plan for its real estate assets, projected to generate over INR 1800 Crores in cash flows over the next six years, with INR 100 Crores expected in the next 18 months from Rainbow Foundations Ltd.

In line with this strategic direction, PVP Ventures has already acquired a 56% stake in Optimus Oncology Pvt. Ltd. for ₹54.73 Crores and a 52% stake in Biohygea Global Private Limited (Medilabs) for ₹7 Crores, with both becoming material subsidiaries. These acquisitions are part of a broader vision to build a portfolio of quality regional brands in healthcare, leveraging Indian talent and technology. The Annual Report also details the re-appointment of Ms. Poonamallee Jayavelu Bhavani as an independent director and the appointment of M/s. ARS & Associates Company Secretaries LLP as secretarial auditors for five years.